Sandbox GGC8

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 19: Line 19:
== Disease ==
== Disease ==
-
GAPDH is expressed in many diseases and disorders. The main diseases and disorders that were confirmed from the expression of GAPDH are cancers and neurodegeneration. It has been confirmed that GAPDH is expressed in many cancers as its antiapoptotic function protects the tumor and cancerous cells in the body. The protection of those cells promotes tumorigeneses and their proliferation. GAPDH also protects against the shortening of telomeres. The shortening of telomeres is caused by chemotherapy. Furthermore, Oxidative Stress impairs protein function. By impairing GAPDH, it will cause the aging and the apoptosis of the cell. GAPDH can also manage to induce the biological aging of the cells which have been proved to maintain tumor growth and production.
+
GAPDH is expressed in many diseases and disorders. The main diseases and disorders that were confirmed from the expression of GAPDH are cancers and neurodegeneration. It has been confirmed that GAPDH is expressed in many cancers as its antiapoptotic function protects the tumor and cancerous cells in the body. The protection of those cells promotes tumorigeneses and their proliferation.<ref>PMID: 16474839</ref> <ref>PMID: 17573533; PMCID: PMC1904167</ref>GAPDH also protects against the shortening of telomeres. The shortening of telomeres is caused by chemotherapy. Furthermore, Oxidative Stress impairs protein function. By impairing GAPDH, it will cause the aging and the apoptosis of the cell. GAPDH can also manage to induce the biological aging of the cells which have been proved to maintain tumor growth and production.
-
When paired with the right protein, GAPDH can be expressed in neurodegenerative diseases. The protein interaction with GAPDH can affect it functions such as energy metabolism, apoptosis, DNA replication, tRNA transport, and DNA repair. When the function of this Protein is affected, it could lead to disorders such as Parkinson’s disease and Huntington’s disease.
+
When paired with the right protein, GAPDH can be expressed in neurodegenerative diseases. The protein interaction with GAPDH can affect it functions such as energy metabolism, apoptosis, DNA replication, tRNA transport, and DNA repair. When the function of this Protein is affected, it could lead to disorders such as Parkinson’s disease and Huntington’s disease.<ref>PMID: 16474839</ref> <ref>PMID: 17573533; PMCID: PMC1904167</ref>
== Relevance ==
== Relevance ==

Revision as of 16:21, 28 April 2021

GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase)

GAPDH

Drag the structure with the mouse to rotate

References

1. Tatton WG, Chalmers-Redman RM, Elstner M, Leesch W, Jagodzinski FB, Stupak DP, Sugrue MM, Tatton NA. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J Neural Transm Suppl. 2000;(60):77-100. doi: 10.1007/978-3-7091-6301-6_5. PMID: 11205159.

2. Carujo S, Estanyol JM, Ejarque A, Agell N, Bachs O, Pujol MJ. Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity. Oncogene. 2006 Jul 6;25(29):4033-42. doi: 10.1038/sj.onc.1209433. Epub 2006 Feb 13. PMID: 16474839.

3. Kosova, A.A., Khodyreva, S.N. & Lavrik, O.I. Role of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in DNA repair. Biochemistry Moscow 82, 643–654 (2017). https://doi.org/10.1134/S0006297917060013

4. Fermani S, Sparla F, Falini G, Martelli PL, Casadio R, Pupillo P, Ripamonti A, Trost P. Molecular mechanism of thioredoxin regulation in photosynthetic A2B2-glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11109-14. doi: 10.1073/pnas.0611636104. Epub 2007 Jun 15. PMID: 17573533; PMCID: PMC1904167.

  1. Carujo S, Estanyol JM, Ejarque A, Agell N, Bachs O, Pujol MJ. Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity. Oncogene. 2006 Jul 6;25(29):4033-42. doi: 10.1038/sj.onc.1209433. Epub 2006 Feb, 13. PMID:16474839 doi:http://dx.doi.org/10.1038/sj.onc.1209433
  2. PMID: 17573533; PMCID: PMC1904167
  3. Tatton WG, Chalmers-Redman RM, Elstner M, Leesch W, Jagodzinski FB, Stupak DP, Sugrue MM, Tatton NA. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J Neural Transm Suppl. 2000;(60):77-100. doi: 10.1007/978-3-7091-6301-6_5. PMID:11205159 doi:http://dx.doi.org/10.1007/978-3-7091-6301-6_5
  4. Tatton WG, Chalmers-Redman RM, Elstner M, Leesch W, Jagodzinski FB, Stupak DP, Sugrue MM, Tatton NA. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J Neural Transm Suppl. 2000;(60):77-100. doi: 10.1007/978-3-7091-6301-6_5. PMID:11205159 doi:http://dx.doi.org/10.1007/978-3-7091-6301-6_5
  5. Carujo S, Estanyol JM, Ejarque A, Agell N, Bachs O, Pujol MJ. Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity. Oncogene. 2006 Jul 6;25(29):4033-42. doi: 10.1038/sj.onc.1209433. Epub 2006 Feb, 13. PMID:16474839 doi:http://dx.doi.org/10.1038/sj.onc.1209433
  6. PMID: 17573533; PMCID: PMC1904167
  7. Carujo S, Estanyol JM, Ejarque A, Agell N, Bachs O, Pujol MJ. Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity. Oncogene. 2006 Jul 6;25(29):4033-42. doi: 10.1038/sj.onc.1209433. Epub 2006 Feb, 13. PMID:16474839 doi:http://dx.doi.org/10.1038/sj.onc.1209433
  8. PMID: 17573533; PMCID: PMC1904167
  9. Tatton WG, Chalmers-Redman RM, Elstner M, Leesch W, Jagodzinski FB, Stupak DP, Sugrue MM, Tatton NA. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J Neural Transm Suppl. 2000;(60):77-100. doi: 10.1007/978-3-7091-6301-6_5. PMID:11205159 doi:http://dx.doi.org/10.1007/978-3-7091-6301-6_5
  10. PMID: 17573533; PMCID: PMC1904167
  11. Tatton WG, Chalmers-Redman RM, Elstner M, Leesch W, Jagodzinski FB, Stupak DP, Sugrue MM, Tatton NA. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J Neural Transm Suppl. 2000;(60):77-100. doi: 10.1007/978-3-7091-6301-6_5. PMID:11205159 doi:http://dx.doi.org/10.1007/978-3-7091-6301-6_5
  12. Carujo S, Estanyol JM, Ejarque A, Agell N, Bachs O, Pujol MJ. Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity. Oncogene. 2006 Jul 6;25(29):4033-42. doi: 10.1038/sj.onc.1209433. Epub 2006 Feb, 13. PMID:16474839 doi:http://dx.doi.org/10.1038/sj.onc.1209433
  13. PMID: 17573533; PMCID: PMC1904167
  14. Carujo S, Estanyol JM, Ejarque A, Agell N, Bachs O, Pujol MJ. Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity. Oncogene. 2006 Jul 6;25(29):4033-42. doi: 10.1038/sj.onc.1209433. Epub 2006 Feb, 13. PMID:16474839 doi:http://dx.doi.org/10.1038/sj.onc.1209433
  15. PMID: 17573533; PMCID: PMC1904167
Personal tools